MINNEAPOLIS, April 3, 2020 /PRNewswire/ — InsurTech Holdings, Life Epigenetics, and YouSurance today announced a rebrand to FOXO BioScience (“FOXO”).
Inspired by new discoveries in human longevity through the lens of the “Epigenetic Clock,” FOXO is the leading developer of epigenetic technology for industries focused on providing cutting-edge molecular biological insights into human health, wellness, disease and aging. FOXO specializes in the identification and development of epigenetic signatures related to biomarkers of human health through the application of leading supervised machine learning and artificial intelligence technologies.
Prior to rebranding, Life Epigenetics and YouSurance were separately focused on delivering innovation to the life insurance industry with step-change underwriting technology and a consumer engagement platform to improve health and wellness. Under the rebrand, FOXO will continue its groundbreaking work to provide support for step-change innovation in the longevity industry, while also expanding the company’s mandate to service additional market verticals with the company’s technology platform.
To that end, FOXO is expanding its line of business to support the greater research community with customizable products and services that foster groundbreaking scientific discoveries in the field of epigenetics. The company was responsible for the important technology transfer that is leading to the upcoming release of the Infinium Mouse Methylation Array. In addition, FOXO continues to bring supporting bioinformatics software packages that facilitate scientific breakthroughs by accelerating and simplifying the processing of complex epigenetic data.
Learn more about FOXO’s products and services:
About FOXO
FOXO BioScience LLC (“FOXO”), is the leader in commercializing epigenetic testing services and technology. Through a series of partnerships and collaborative relationships, FOXO is developing cutting-edge molecular biology insights for commercial applications that support scientific research, groundbreaking discoveries, and disruptive business initiatives. FOXO offers high throughput laboratory services, bioinformatics, and epigenetic signature discovery and development to researchers and businesses seeking to commercially apply novel epigenetic mechanisms involved in health, wellness, disease and aging. For more information about FOXO, visit www.FoxoBioScience.com or email PR@FoxoBioScience.com.
View original content to download multimedia:http://www.prnewswire.com/news-releases/insurtech-holdings-life-epigenetics-and-yousurance-are-rebranding-to-foxo-bioscience-301034964.html
SOURCE FOXO BioScience
Community Gains Nearly 144 Million Minutes of Sleep, Wins Best Sleep Wearable of 2025NEW YORK,…
COLUMBIA, Mo., Jan. 30, 2026 /PRNewswire/ -- Paytient, a leader in innovative healthcare affordability and…
Burlington, Ontario--(Newsfile Corp. - January 30, 2026) - Promino Nutritional Sciences Inc. (CSE: MUSL) (OTC:…
Toronto, Ontario--(Newsfile Corp. - January 30, 2026) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen"…
New Plug-In BLE Sensors provide a faster, more cost-effective path to facility-wide RTLS coverage with near-room…
DANVILLE, Calif., Jan. 30, 2026 /PRNewswire/ -- Vrtly, Inc., the premier point-of-care (POC) marketing platform…